when were glp 1 drugs approved Comparing Ozempic, Wegovy and Other GLP-1 History of GLP-1 Medications -

[DOI] [Google Scholar] 32.Li J.-M., Gall N

(Lausanne) 13 , 880503 (2022)

This document does not constitute professional or legal advice

Some people experience no gastrointestinal issues with tirzepatide but cannot tolerate semaglutide, or vice versa

JAMA (2019) 321:1457

Additional well-designed, prospective studies are needed to confirm the potential benefit of GLP-1 receptor agonist treatment for patients with advanced CKD or ESKD." For further information: DOI: 10.1001/jamanetworkopen.2022.1169 Keywords: CKD, ESKD, GLP-1 receptor agonist, DPP-4 inhibitors, type 2 diabetes, JAMA Network Open, chronic kidney disease, end-stage kidney disease, National Health Insurance Research Database of Taiwan, MACCE, Mortality rate